KINEXON, one of the world’s leading providers of real-time sports performance tracking and analytics, and the Football Science Institute, a global platform of professionals, teachers and experts for the development of football, reach a strategic technology collaboration agreement to generate and coordinate activities between both companies.
With this agreement, KINEXON and FSI strengthen their joint objective of promoting new methodologies of work and training. Both companies will work together on research projects and training actions that Football Science Institute is developing with prestigious football clubs, aimed at the entire international professional football community.
FSI will use all KINEXON player and ball live tracking and analysis solutions in their facility in Granada and apply KINEXON technology in their scientific studies and publications. Furthermore, both companies will take advantage of synergy effects from their joint football networks.
Hansen, Head of Clubs & Federations Europe at KINEXON, emphasizes the huge potential of the collaboration: “Both brands will strongly benefit from each other’s network and knowledge. In addition, we are looking forward to getting detailed exclusive feedback from FSI without any filter and on the background of well-founded experience and expertise.” KINEXON Sports & Media GmbH KINEXON is a multi-award winning global innovator in intelligent real-time location, analytics, and automation for sports and industry applications.
In sports, more than 400 teams & leagues worldwide rely on KINEXON for performance tracking & analytics, load management, tactical analysis, and fan engagement – including, among others, more than 75% of NBA franchises and about one in three German Bundesliga football teams. In addition, KINEXON is the only FIFA Preferred Provider Live Player Tracking. KINEXON gained international media fame during the COVID-19 pandemic with its innovation KINEXON SafeZone. The wearable solution is considered the world’s most trusted digital solution to mitigate the spread of COVID-19.
Founded in 2012 by scientists at the Technical University of Munich and headquartered in Munich, Germany, KINEXON has grown to more than 250 employees in offices in Munich, New York, and Chicago.
More information can be found at www.kinexon.com.
